Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects

NCT00619346 is registered in ClinicalTrials.gov with Immtech Pharmaceuticals, Inc as lead sponsor.

NCT NCT00619346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects
Lead sponsor
Immtech Pharmaceuticals, Inc
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2007
Completion date
February 28, 2009
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy